Skip to main content

Table 4 Original and revised headache treatments

From: Treatment of primary headache in children: a multicenter hospital-based study in France

 

Original treatment, n (%)

Revised treatment, n (%)

Change

Acute headache treatments

 NSAIDS

175 (55.9)

202 (64.5)

1.15

 Paracetamol

260 (83.1)

66 (21.1)

0.25

 Ergot alkaloid

5 (1.6)

3 (1.0)

0.60

 Triptan

9 (2.9)

58 (18.5)

6.44

 Analgesics

4 (1.3)

None

 None

16 (5.1)

43 (13.7)

2.69

Prophylactic treatments

 Antiserotonergics

13 (4.2)

28 (9.0)

2.15

 Tricyclics

1 (0.3)

8 (2.6)

8.00

 Beta blockers

1 (0.3)

5 (1.6)

5.00

 Ca channel blockers

4 (1.3)

7 (2.2)

1.75

 Ergot alkaloids

25 (8.0)

14 (4.5)

0.56

 Antiepileptic drugs

2 (0.6)

2 (0.6)

1.00

 No prophylaxis

279 (89.1)

249 (79.6)

0.89

Non-pharmacological treatments

 Psychotherapy

7 (2.2)

33 (10.5)

4.71

 Relaxation

2 (0.6)

43 (13.7)

21.50

 Biofeedback

None

8 (2.6)

  1. Data are presented for the 313 children for whom an ICHD-II headache diagnosis could be assigned. Categories are non-exclusive, since children could be prescribed more than one treatment. The ‘change’ column represents the ratio between the revised treatment and the original treatment